Investment Trusts

BioPharma Credit PLC

BPCR:LSE

BioPharma Credit PLC

Actions
  • Price (USD)0.89
  • Today's Change0.008 / 0.91%
  • Shares traded243.40k
  • 1 Year change+8.27%
  • Beta0.2893
Data delayed at least 20 minutes, as of Sep 16 2024 11:43 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on $1000

1Y
Fund/benchmarkChange
PriceBioPharma Credit PLC (Ordinary Share)+19.85%
NAVBioPharma Credit PLC (Ordinary Share)+9.09%
Morningstar's BenchmarkNo benchmark--

Key statistics

As of last trade BioPharma Credit PLC (BPCR:LSE) traded at 0.89, -5.72% below its 52-week high of 0.944, set on Jan 30, 2024.
52-week range
Today
0.81Nov 09 20230.944Jan 30 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding1.20bn
Market cap1.05bn USD
Total assets1.21bn USD
Total expense ratio1.15%
High0.896
Low0.888
Previous close0.882
Average volume981.71k
YTD Change+5.95%
Beta0.2893
Diluted NAV (est)1.01
Diluted NAV (last pub)0.998
Premium/Discount-12.31%
Net Gearing0.00%
Annual div (ADY)0.07
USD
Annual div yield (ADY)7.94%
Div ex-dateJul 04 2024
Div pay-dateJul 31 2024
Data delayed at least 20 minutes, as of Sep 16 2024 11:43 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.